Catriona Yale - Net Worth and Insider Trading
Catriona Yale Net Worth
The estimated net worth of Catriona Yale is at least $2 Million dollars as of 2024-10-10. Catriona Yale is the Chief Development Officer of Akero Therapeutics Inc and owns about 75,294 shares of Akero Therapeutics Inc (AKRO) stock worth over $2 Million. Details can be seen in Catriona Yale's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Catriona Yale has not made any transactions after 2024-09-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Catriona Yale
Catriona Yale Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Catriona Yale owns 1 companies in total, including Akero Therapeutics Inc (AKRO) .
Click here to see the complete history of Catriona Yale’s form 4 insider trades.
Insider Ownership Summary of Catriona Yale
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AKRO | Akero Therapeutics Inc | 2024-09-20 | Chief Development Officer |
Catriona Yale Latest Holdings Summary
Catriona Yale currently owns a total of 1 stock. Catriona Yale owns 75,294 shares of Akero Therapeutics Inc (AKRO) as of September 20, 2024, with a value of $2 Million.
Latest Holdings of Catriona Yale
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AKRO | Akero Therapeutics Inc | 2024-09-20 | 75,294 | 28.51 | 2,146,632 |
Holding Weightings of Catriona Yale
Catriona Yale Form 4 Trading Tracker
According to the SEC Form 4 filings, Catriona Yale has made a total of 22 transactions in Akero Therapeutics Inc (AKRO) over the past 5 years, including 0 buys and 22 sells. The most-recent trade in Akero Therapeutics Inc is the sale of 5,500 shares on September 20, 2024, which brought Catriona Yale around $152,075.
Insider Trading History of Catriona Yale
- 1
Catriona Yale Trading Performance
Catriona Yale Ownership Network
Catriona Yale Owned Company Details
What does Akero Therapeutics Inc do?
Who are the key executives at Akero Therapeutics Inc?
Catriona Yale is the Chief Development Officer of Akero Therapeutics Inc. Other key executives at Akero Therapeutics Inc include Chief Operating Officer Jonathan Young , director & President & CEO Andrew Cheng , and Chief Financial Officer William Richard White .
Akero Therapeutics Inc (AKRO) Insider Trades Summary
Over the past 18 months, Catriona Yale made 13 insider transaction in Akero Therapeutics Inc (AKRO) with a net sale of 99,623. Other recent insider transactions involving Akero Therapeutics Inc (AKRO) include a net sale of 81,282 shares made by Jonathan Young , a net sale of 268,502 shares made by Andrew Cheng , and a net sale of 321,820 shares made by William Richard White .
In summary, during the past 3 months, insiders sold 348,012 shares of Akero Therapeutics Inc (AKRO) in total and bought 0 shares, with a net sale of 348,012 shares. During the past 18 months, 921,086 shares of Akero Therapeutics Inc (AKRO) were sold and 1,320,000 shares were bought by its insiders, resulting in a net purchase of 398,914 shares.
Akero Therapeutics Inc (AKRO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Akero Therapeutics Inc Insider Transactions
Catriona Yale Mailing Address
Above is the net worth, insider trading, and ownership report for Catriona Yale. You might contact Catriona Yale via mailing address: C/o Akero Therapeutics Inc., 170 Harbor Way 3rd Floor, South San Francisco Ca 94080.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
